Authors:
Reichert, A
Frohlich, R
Ferguson, R
Kraft, A
Citation: A. Reichert et al., Binding interactions between 3-aryl-1,2,4-oxadiazol-5-ones and a trisimidazoline base, J CHEM S P1, (11), 2001, pp. 1321-1328
Authors:
Heisterkamp, N
Voncken, JW
Senadheera, D
Hemmeryckx, B
Gonzalez-Gomez, I
Reichert, A
Pattengale, PK
Groffen, J
Citation: N. Heisterkamp et al., The Bcr N-terminal oligomerization domain contributes to the full oncogenicity of P190 Bcr/Abl in transgenic mice, INT J MOL M, 7(4), 2001, pp. 351-357
Authors:
Reichert, A
Heisterkamp, N
Daley, GQ
Groffen, J
Citation: A. Reichert et al., Treatment of Bcr/Abl-positive acute lymphoblastic leukemia in P190 transgenic mice with the farnesyl transferase inhibitor SCH66336, BLOOD, 97(5), 2001, pp. 1399-1403
Citation: A. Kraft et al., Supramolecular liquid crystals with columnar mesophases through self-assembly of carboxylic acids around a tribasic core, CHEM COMMUN, (12), 2000, pp. 1015-1016
Authors:
Seifarth, W
Baust, C
Schon, U
Reichert, A
Hehlmann, R
Leib-Mosch, C
Citation: W. Seifarth et al., HERV-IP-T47D, a novel type C-related human endogenous retroviral sequence derived from T47D particles, AIDS RES H, 16(5), 2000, pp. 471-480
Authors:
Lengfelder, E
Reichert, A
Schoch, C
Haase, D
Haferlach, T
Loffler, H
Staib, P
Heyll, A
Seifarth, W
Saussele, S
Fonatsch, C
Gassmann, W
Ludwig, WD
Hochhaus, A
Beelen, D
Aul, C
Sauerland, MC
Heinecke, A
Hehlmann, R
Wormann, B
Hiddemann, W
Buchner, T
Citation: E. Lengfelder et al., Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia, LEUKEMIA, 14(8), 2000, pp. 1362-1370
Authors:
Reichert, A
Baalmann, E
Vetter, S
Backhausen, JE
Scheibe, R
Citation: A. Reichert et al., Activation properties of the redox-modulated chloroplast enzymes glyceraldehyde 3-phosphate dehydrogenase and fructose-1,6-bisphosphatase, PHYSL PLANT, 110(3), 2000, pp. 330-341
Authors:
Hochhaus, A
Reiter, A
Saussele, S
Reichert, A
Emig, M
Kaeda, J
Schultheis, B
Berger, U
Shepherd, PCA
Allan, NC
Hehlmann, R
Goldman, JM
Cross, NCP
Citation: A. Hochhaus et al., Molecular heterogeneity in complete cytogenetic responders after interferon-alpha therapy for chronic myelogenous leukemia: low levels of minimal residual disease are associated with continuing remission, BLOOD, 95(1), 2000, pp. 62-66
Citation: A. Kraft et A. Reichert, Branched non-covalent complexes from carboxylic acids and a tris(tetrahydropyrimidine) base, TETRAHEDRON, 55(13), 1999, pp. 3923-3930